Add to ORKGGranulin-epithelin precursor (GEP), a pluripotent growth factor, is a hepatic oncofetal protein defining a cancer stem cell (CSC) population in liver cancer. The present invention provides the use of GEP inhibitors (including anti-GEP antibody) for inhibiting immune evasion by liver cancer cells and for eliminating liver cancer stem cells.published_or_final_versio
Background & Aims: Chemotherapy is used to treat unresectable liver cancer with marginal efficacy; t...
Background and Aims: Increasing evidence has suggested that hepatocellular carcinoma (HCC) might ori...
Abstract Background Granulin-epithelin precursor (GEP) is a secretory growth factor, which has been ...
This invention provides methods for detecting serum GEP level. This invention further provides metho...
This invention provides methods for detecting serum GEP level. This invention further provides metho...
This invention further provides methods for determining whether an agent causes a reduction in the a...
Conference Theme: Harnessing Breakthroughs - Targeting CuresSession - Experimental and Molecular The...
This invention further provides methods for determining whether an agent causes a reduction in the a...
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third leading cause of ca...
Conference Theme: Molecular Targets and Cancer TherapeuticsHepatocellular carcinoma (HCC) is the maj...
Increasing evidence has suggested that hepatocellular carcinoma (HCC) might originate from a distinc...
BACKGROUND AND AIMS: Increasing evidence has suggested that hepatocellular carcinoma (HCC) might ori...
This journal suppl. entitled: Proceedings: AACR 101st Annual Meeting 2010...Poster Presentations - M...
Poster Presentations - Cancer Stem Cell Biology 2: abstract 4246This journal suppl. entitled: Procee...
This journal suppl. entitled: Proceedings: AACR 101st Annual Meeting 2010...Poster Presentations - O...
Background & Aims: Chemotherapy is used to treat unresectable liver cancer with marginal efficacy; t...
Background and Aims: Increasing evidence has suggested that hepatocellular carcinoma (HCC) might ori...
Abstract Background Granulin-epithelin precursor (GEP) is a secretory growth factor, which has been ...
This invention provides methods for detecting serum GEP level. This invention further provides metho...
This invention provides methods for detecting serum GEP level. This invention further provides metho...
This invention further provides methods for determining whether an agent causes a reduction in the a...
Conference Theme: Harnessing Breakthroughs - Targeting CuresSession - Experimental and Molecular The...
This invention further provides methods for determining whether an agent causes a reduction in the a...
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third leading cause of ca...
Conference Theme: Molecular Targets and Cancer TherapeuticsHepatocellular carcinoma (HCC) is the maj...
Increasing evidence has suggested that hepatocellular carcinoma (HCC) might originate from a distinc...
BACKGROUND AND AIMS: Increasing evidence has suggested that hepatocellular carcinoma (HCC) might ori...
This journal suppl. entitled: Proceedings: AACR 101st Annual Meeting 2010...Poster Presentations - M...
Poster Presentations - Cancer Stem Cell Biology 2: abstract 4246This journal suppl. entitled: Procee...
This journal suppl. entitled: Proceedings: AACR 101st Annual Meeting 2010...Poster Presentations - O...
Background & Aims: Chemotherapy is used to treat unresectable liver cancer with marginal efficacy; t...
Background and Aims: Increasing evidence has suggested that hepatocellular carcinoma (HCC) might ori...
Abstract Background Granulin-epithelin precursor (GEP) is a secretory growth factor, which has been ...